

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.69875426 |
| 2 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.31668519 |
| 3 | positive regulation of granulocyte differentiation (GO:0030854) | 5.11249072 |
| 4 | regulation of gamma-delta T cell activation (GO:0046643) | 4.79028823 |
| 5 | negative T cell selection (GO:0043383) | 4.73349708 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.54718001 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.54718001 |
| 8 | histone H3-K36 demethylation (GO:0070544) | 4.27764425 |
| 9 | positive thymic T cell selection (GO:0045059) | 4.26006886 |
| 10 | positive T cell selection (GO:0043368) | 4.24851556 |
| 11 | negative thymic T cell selection (GO:0045060) | 4.18758127 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.15133338 |
| 13 | T cell selection (GO:0045058) | 3.98310005 |
| 14 | thymic T cell selection (GO:0045061) | 3.82761914 |
| 15 | regulation of granulocyte differentiation (GO:0030852) | 3.80711133 |
| 16 | mast cell degranulation (GO:0043303) | 3.80690575 |
| 17 | mast cell activation involved in immune response (GO:0002279) | 3.80690575 |
| 18 | nuclear pore complex assembly (GO:0051292) | 3.76602387 |
| 19 | V(D)J recombination (GO:0033151) | 3.71684833 |
| 20 | mitotic sister chromatid cohesion (GO:0007064) | 3.71539287 |
| 21 | negative regulation of T cell mediated immunity (GO:0002710) | 3.60287055 |
| 22 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.58944935 |
| 23 | negative regulation of T cell apoptotic process (GO:0070233) | 3.57372694 |
| 24 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.57065939 |
| 25 | mast cell activation (GO:0045576) | 3.55730649 |
| 26 | negative regulation of cell killing (GO:0031342) | 3.48689365 |
| 27 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.48689365 |
| 28 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.41805235 |
| 29 | response to interleukin-15 (GO:0070672) | 3.40513873 |
| 30 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.40107567 |
| 31 | T-helper cell differentiation (GO:0042093) | 3.40107567 |
| 32 | nuclear pore organization (GO:0006999) | 3.36462206 |
| 33 | interferon-gamma production (GO:0032609) | 3.35667984 |
| 34 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.35450540 |
| 35 | positive regulation of histone deacetylation (GO:0031065) | 3.31991280 |
| 36 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.31203270 |
| 37 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.26082678 |
| 38 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.26082678 |
| 39 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.25118503 |
| 40 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.24424682 |
| 41 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.23745263 |
| 42 | tolerance induction (GO:0002507) | 3.21552784 |
| 43 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.18157804 |
| 44 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.17975179 |
| 45 | DNA unwinding involved in DNA replication (GO:0006268) | 3.07915825 |
| 46 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.03743787 |
| 47 | regulation of RNA export from nucleus (GO:0046831) | 3.03568813 |
| 48 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.03280318 |
| 49 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.01398552 |
| 50 | regulation of B cell differentiation (GO:0045577) | 3.00969092 |
| 51 | T cell costimulation (GO:0031295) | 3.00521992 |
| 52 | positive regulation of B cell differentiation (GO:0045579) | 2.99873712 |
| 53 | T cell receptor signaling pathway (GO:0050852) | 2.97044216 |
| 54 | T cell differentiation involved in immune response (GO:0002292) | 2.96424072 |
| 55 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.96424072 |
| 56 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.96424072 |
| 57 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.95612278 |
| 58 | regulation of T cell tolerance induction (GO:0002664) | 2.94550656 |
| 59 | lymphocyte costimulation (GO:0031294) | 2.93606697 |
| 60 | leukocyte degranulation (GO:0043299) | 2.92769877 |
| 61 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.92056367 |
| 62 | cellular extravasation (GO:0045123) | 2.89276556 |
| 63 | positive regulation of cell killing (GO:0031343) | 2.87958272 |
| 64 | negative regulation of histone methylation (GO:0031061) | 2.84641289 |
| 65 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.83472936 |
| 66 | pore complex assembly (GO:0046931) | 2.82688261 |
| 67 | activated T cell proliferation (GO:0050798) | 2.82285173 |
| 68 | regulation of histone H3-K9 methylation (GO:0051570) | 2.80382048 |
| 69 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.79822511 |
| 70 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.79822511 |
| 71 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.79404356 |
| 72 | regulation of regulatory T cell differentiation (GO:0045589) | 2.78386391 |
| 73 | regulation of necroptotic process (GO:0060544) | 2.78379915 |
| 74 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.78182425 |
| 75 | B cell receptor signaling pathway (GO:0050853) | 2.77927360 |
| 76 | positive regulation by host of viral transcription (GO:0043923) | 2.76905740 |
| 77 | cellular response to interleukin-15 (GO:0071350) | 2.76822027 |
| 78 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.74030844 |
| 79 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.73876811 |
| 80 | leukocyte aggregation (GO:0070486) | 2.73767016 |
| 81 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.73749818 |
| 82 | pre-miRNA processing (GO:0031054) | 2.72667283 |
| 83 | T cell homeostasis (GO:0043029) | 2.72616639 |
| 84 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.72033724 |
| 85 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.71462900 |
| 86 | mRNA cleavage (GO:0006379) | 2.70316337 |
| 87 | regulation of cell killing (GO:0031341) | 2.68822403 |
| 88 | positive regulation of interleukin-2 production (GO:0032743) | 2.67374765 |
| 89 | mitotic chromosome condensation (GO:0007076) | 2.66284121 |
| 90 | natural killer cell differentiation (GO:0001779) | 2.65957428 |
| 91 | definitive hemopoiesis (GO:0060216) | 2.65897026 |
| 92 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.65663156 |
| 93 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.65200667 |
| 94 | lymph node development (GO:0048535) | 2.64893647 |
| 95 | T cell differentiation (GO:0030217) | 2.64598166 |
| 96 | positive regulation of T cell chemotaxis (GO:0010820) | 2.64569344 |
| 97 | regulation of T cell chemotaxis (GO:0010819) | 2.64569344 |
| 98 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.63833341 |
| 99 | hepatocyte apoptotic process (GO:0097284) | 2.62612382 |
| 100 | TOR signaling (GO:0031929) | 2.62228950 |
| 101 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.61755369 |
| 102 | regulation of alpha-beta T cell activation (GO:0046634) | 2.58235638 |
| 103 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.57842730 |
| 104 | positive regulation of tolerance induction (GO:0002645) | 2.57523742 |
| 105 | T cell proliferation (GO:0042098) | 2.57493390 |
| 106 | regulation of histone H3-K27 methylation (GO:0061085) | 2.55383110 |
| 107 | positive regulation of protein deacetylation (GO:0090312) | 2.55341112 |
| 108 | T cell migration (GO:0072678) | 2.52794378 |
| 109 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.50952762 |
| 110 | Peyers patch development (GO:0048541) | 2.50952762 |
| 111 | mitotic nuclear envelope disassembly (GO:0007077) | 2.50599996 |
| 112 | RNA stabilization (GO:0043489) | 2.50597236 |
| 113 | mRNA stabilization (GO:0048255) | 2.50597236 |
| 114 | DNA duplex unwinding (GO:0032508) | 2.49765730 |
| 115 | heterochromatin organization (GO:0070828) | 2.48974043 |
| 116 | regulation of thymocyte apoptotic process (GO:0070243) | 2.48368629 |
| 117 | dosage compensation (GO:0007549) | 2.48229844 |
| 118 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.46547003 |
| 119 | protein localization to kinetochore (GO:0034501) | 2.46196917 |
| 120 | lymphocyte homeostasis (GO:0002260) | 2.46049856 |
| 121 | histone mRNA catabolic process (GO:0071044) | 2.45983458 |
| 122 | DNA geometric change (GO:0032392) | 2.45874415 |
| 123 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.44420918 |
| 124 | alpha-beta T cell activation (GO:0046631) | 2.44128204 |
| 125 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.41850043 |
| 126 | positive regulation of isotype switching (GO:0045830) | 2.40584111 |
| 127 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.40168710 |
| 128 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.40155378 |
| 129 | cellular hyperosmotic response (GO:0071474) | 2.39533452 |
| 130 | somatic cell DNA recombination (GO:0016444) | 2.36426471 |
| 131 | somatic diversification of immune receptors via germline recombination within a single locus (GO:000 | 2.36426471 |
| 132 | alpha-beta T cell differentiation (GO:0046632) | 2.36391901 |
| 133 | negative regulation of phagocytosis (GO:0050765) | 2.36334616 |
| 134 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.31814412 |
| 135 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.31356051 |
| 136 | nuclear envelope disassembly (GO:0051081) | 2.31077212 |
| 137 | membrane disassembly (GO:0030397) | 2.31077212 |
| 138 | NLS-bearing protein import into nucleus (GO:0006607) | 2.30878213 |
| 139 | regulation of DNA endoreduplication (GO:0032875) | 2.30766461 |
| 140 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.30730260 |
| 141 | response to UV-C (GO:0010225) | 2.30234575 |
| 142 | protein localization to chromosome, centromeric region (GO:0071459) | 2.28737362 |
| 143 | negative regulation of RNA splicing (GO:0033119) | 2.28719720 |
| 144 | regulation of translational fidelity (GO:0006450) | 2.28419890 |
| 145 | chromatin assembly (GO:0031497) | 2.27904788 |
| 146 | regulation of response to interferon-gamma (GO:0060330) | 2.27641769 |
| 147 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.27583531 |
| 148 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.26095453 |
| 149 | T cell differentiation in thymus (GO:0033077) | 2.25998124 |
| 150 | germ cell migration (GO:0008354) | 2.24847121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.14798365 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.53954006 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.07116420 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.92941479 |
| 5 | * MYC_22102868_ChIP-Seq_BL_Human | 3.70318623 |
| 6 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.44449459 |
| 7 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.25293597 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.95475393 |
| 9 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.90696485 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.70489587 |
| 11 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.43443388 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.41471110 |
| 13 | * MYB_26560356_Chip-Seq_TH2_Human | 2.31940414 |
| 14 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.30859934 |
| 15 | MAF_26560356_Chip-Seq_TH1_Human | 2.26084765 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.20594484 |
| 17 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.15965827 |
| 18 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.15930655 |
| 19 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.12187432 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.10614073 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.09629222 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.04497845 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02590908 |
| 24 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.98767391 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.96744302 |
| 26 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.92600997 |
| 27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.86104760 |
| 28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.86054899 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83312154 |
| 30 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.80471545 |
| 31 | GATA3_26560356_Chip-Seq_TH2_Human | 1.79532376 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.79071308 |
| 33 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.75785390 |
| 34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.73645892 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.69969655 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.66980139 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.63953266 |
| 38 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.63240393 |
| 39 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.62242234 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.59876591 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59863042 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.58077286 |
| 43 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.55003807 |
| 44 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54774481 |
| 45 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.52377446 |
| 46 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48368830 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.48021044 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.46911243 |
| 49 | MAF_26560356_Chip-Seq_TH2_Human | 1.44885132 |
| 50 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.44150165 |
| 51 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42671232 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.39993401 |
| 53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37667525 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.35691064 |
| 55 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33991562 |
| 56 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33234271 |
| 57 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33012749 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30578188 |
| 59 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.28984818 |
| 60 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28411062 |
| 61 | GATA2_19941826_ChIP-Seq_K562_Human | 1.27944604 |
| 62 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.26144846 |
| 63 | GATA1_19941826_ChIP-Seq_K562_Human | 1.24946526 |
| 64 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.24091408 |
| 65 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23694535 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21217737 |
| 67 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.21208447 |
| 68 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20826878 |
| 69 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.20330484 |
| 70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19684040 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19427394 |
| 72 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.15507251 |
| 73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.14954896 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12428296 |
| 75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12289053 |
| 76 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.11808621 |
| 77 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10573631 |
| 78 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10570795 |
| 79 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10351354 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10001393 |
| 81 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09956472 |
| 82 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.08555156 |
| 83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.08142128 |
| 84 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06038073 |
| 85 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05595169 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04606214 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04579919 |
| 88 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.04439444 |
| 89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04361343 |
| 90 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03982342 |
| 91 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.00827679 |
| 92 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00164352 |
| 93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99761497 |
| 94 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97836126 |
| 95 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97398609 |
| 96 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96805710 |
| 97 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.96663460 |
| 98 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95809085 |
| 99 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95728373 |
| 100 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95391940 |
| 101 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.94511363 |
| 102 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.94493739 |
| 103 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93749803 |
| 104 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.93660216 |
| 105 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91648911 |
| 106 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.91099480 |
| 107 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90899065 |
| 108 | * GATA3_26560356_Chip-Seq_TH1_Human | 0.90783965 |
| 109 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89773971 |
| 110 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.89370415 |
| 111 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88795555 |
| 112 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88286514 |
| 113 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.88181621 |
| 114 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87473311 |
| 115 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86234371 |
| 116 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.85953983 |
| 117 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.85659417 |
| 118 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85020637 |
| 119 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.84736619 |
| 120 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84718002 |
| 121 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.84463037 |
| 122 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.84155798 |
| 123 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.83744112 |
| 124 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.83536267 |
| 125 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83467709 |
| 126 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.83465690 |
| 127 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.82878238 |
| 128 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.82509352 |
| 129 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81711977 |
| 130 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.81439058 |
| 131 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.81310347 |
| 132 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.81159306 |
| 133 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80142458 |
| 134 | ATF3_27146783_Chip-Seq_COLON_Human | 0.79385548 |
| 135 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.79179879 |
| 136 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78975675 |
| 137 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.78819054 |
| 138 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77910949 |
| 139 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77261217 |
| 140 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75115304 |
| 141 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.75061450 |
| 142 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.72962036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004381_abnormal_hair_follicle | 3.14554630 |
| 2 | MP0005075_abnormal_melanosome_morpholog | 3.13277638 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.13213053 |
| 4 | MP0002166_altered_tumor_susceptibility | 2.70887490 |
| 5 | MP0003300_gastrointestinal_ulcer | 2.61095360 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.58878965 |
| 7 | MP0003724_increased_susceptibility_to | 2.48428064 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.45784537 |
| 9 | MP0000685_abnormal_immune_system | 2.42792843 |
| 10 | MP0001800_abnormal_humoral_immune | 2.27200653 |
| 11 | MP0005671_abnormal_response_to | 2.24284165 |
| 12 | MP0004808_abnormal_hematopoietic_stem | 2.07974866 |
| 13 | * MP0002398_abnormal_bone_marrow | 2.07442412 |
| 14 | * MP0000703_abnormal_thymus_morphology | 2.06996791 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.05410041 |
| 16 | MP0002006_tumorigenesis | 2.03579250 |
| 17 | MP0005387_immune_system_phenotype | 2.01611267 |
| 18 | MP0001790_abnormal_immune_system | 2.01611267 |
| 19 | MP0005076_abnormal_cell_differentiation | 1.97363037 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.89672098 |
| 21 | MP0003705_abnormal_hypodermis_morpholog | 1.85897791 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 1.82033290 |
| 23 | MP0004947_skin_inflammation | 1.81532699 |
| 24 | MP0010094_abnormal_chromosome_stability | 1.79869870 |
| 25 | * MP0002722_abnormal_immune_system | 1.76935527 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.76849617 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.75646366 |
| 28 | MP0001873_stomach_inflammation | 1.75143471 |
| 29 | * MP0002420_abnormal_adaptive_immunity | 1.73193426 |
| 30 | MP0009278_abnormal_bone_marrow | 1.73086641 |
| 31 | MP0000689_abnormal_spleen_morphology | 1.72637573 |
| 32 | * MP0001819_abnormal_immune_cell | 1.69789069 |
| 33 | * MP0000716_abnormal_immune_system | 1.69443555 |
| 34 | MP0008057_abnormal_DNA_replication | 1.69356066 |
| 35 | MP0002723_abnormal_immune_serum | 1.67960613 |
| 36 | MP0002405_respiratory_system_inflammati | 1.62205096 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.61685094 |
| 38 | MP0000569_abnormal_digit_pigmentation | 1.61080870 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.59841524 |
| 40 | MP0003077_abnormal_cell_cycle | 1.56007508 |
| 41 | MP0010307_abnormal_tumor_latency | 1.55800752 |
| 42 | MP0003303_peritoneal_inflammation | 1.55499586 |
| 43 | MP0000015_abnormal_ear_pigmentation | 1.54869182 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.48648646 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.48648646 |
| 46 | * MP0002429_abnormal_blood_cell | 1.47682093 |
| 47 | MP0003693_abnormal_embryo_hatching | 1.46334098 |
| 48 | MP0005451_abnormal_body_composition | 1.45636459 |
| 49 | MP0006054_spinal_hemorrhage | 1.43572262 |
| 50 | MP0004957_abnormal_blastocyst_morpholog | 1.37367745 |
| 51 | MP0003436_decreased_susceptibility_to | 1.36118061 |
| 52 | MP0003111_abnormal_nucleus_morphology | 1.35215451 |
| 53 | MP0000490_abnormal_crypts_of | 1.33010465 |
| 54 | MP0003566_abnormal_cell_adhesion | 1.32157773 |
| 55 | MP0002933_joint_inflammation | 1.31066260 |
| 56 | MP0003828_pulmonary_edema | 1.28240428 |
| 57 | MP0005025_abnormal_response_to | 1.28219303 |
| 58 | MP0005023_abnormal_wound_healing | 1.24797820 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.23993251 |
| 60 | MP0010234_abnormal_vibrissa_follicle | 1.22888092 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.21165867 |
| 62 | MP0000350_abnormal_cell_proliferation | 1.20387257 |
| 63 | MP0002148_abnormal_hypersensitivity_rea | 1.20212464 |
| 64 | MP0009785_altered_susceptibility_to | 1.18978191 |
| 65 | MP0005310_abnormal_salivary_gland | 1.17731819 |
| 66 | MP0001730_embryonic_growth_arrest | 1.16837034 |
| 67 | MP0001661_extended_life_span | 1.15042210 |
| 68 | MP0005464_abnormal_platelet_physiology | 1.12960762 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.12444928 |
| 70 | MP0000733_abnormal_muscle_development | 1.11575252 |
| 71 | MP0001849_ear_inflammation | 1.10917262 |
| 72 | MP0004197_abnormal_fetal_growth/weight/ | 1.10323311 |
| 73 | MP0000858_altered_metastatic_potential | 1.08330957 |
| 74 | MP0000465_gastrointestinal_hemorrhage | 1.08178752 |
| 75 | MP0003806_abnormal_nucleotide_metabolis | 1.05903083 |
| 76 | MP0005408_hypopigmentation | 1.05379455 |
| 77 | MP0002877_abnormal_melanocyte_morpholog | 1.05101100 |
| 78 | MP0003866_abnormal_defecation | 1.04921900 |
| 79 | MP0001853_heart_inflammation | 1.04423173 |
| 80 | MP0006082_CNS_inflammation | 1.03679388 |
| 81 | * MP0002086_abnormal_extraembryonic_tissu | 1.03270494 |
| 82 | MP0002009_preneoplasia | 0.99951260 |
| 83 | MP0004264_abnormal_extraembryonic_tissu | 0.99365848 |
| 84 | MP0002419_abnormal_innate_immunity | 0.98713851 |
| 85 | MP0003448_altered_tumor_morphology | 0.97569517 |
| 86 | MP0009697_abnormal_copulation | 0.97325001 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.96349145 |
| 88 | MP0003646_muscle_fatigue | 0.96254058 |
| 89 | * MP0002088_abnormal_embryonic_growth/wei | 0.95289492 |
| 90 | * MP0003984_embryonic_growth_retardation | 0.95167356 |
| 91 | MP0003453_abnormal_keratinocyte_physiol | 0.94974213 |
| 92 | MP0008007_abnormal_cellular_replicative | 0.94448447 |
| 93 | MP0002132_abnormal_respiratory_system | 0.92928019 |
| 94 | MP0001243_abnormal_dermal_layer | 0.92226651 |
| 95 | MP0008469_abnormal_protein_level | 0.91920622 |
| 96 | * MP0001672_abnormal_embryogenesis/_devel | 0.90390668 |
| 97 | * MP0005380_embryogenesis_phenotype | 0.90390668 |
| 98 | MP0004130_abnormal_muscle_cell | 0.88943661 |
| 99 | MP0003252_abnormal_bile_duct | 0.88453303 |
| 100 | MP0000371_diluted_coat_color | 0.88145255 |
| 101 | MP0003567_abnormal_fetal_cardiomyocyte | 0.86585552 |
| 102 | MP0000609_abnormal_liver_physiology | 0.86331343 |
| 103 | MP0001915_intracranial_hemorrhage | 0.85443037 |
| 104 | MP0003091_abnormal_cell_migration | 0.84464822 |
| 105 | MP0008995_early_reproductive_senescence | 0.83528468 |
| 106 | MP0003045_fibrosis | 0.83283361 |
| 107 | MP0008961_abnormal_basal_metabolism | 0.83280530 |
| 108 | * MP0001697_abnormal_embryo_size | 0.83225910 |
| 109 | MP0001919_abnormal_reproductive_system | 0.82703725 |
| 110 | MP0005410_abnormal_fertilization | 0.82267262 |
| 111 | MP0009115_abnormal_fat_cell | 0.82017144 |
| 112 | MP0008004_abnormal_stomach_pH | 0.81750220 |
| 113 | MP0001216_abnormal_epidermal_layer | 0.80260045 |
| 114 | MP0000383_abnormal_hair_follicle | 0.79758095 |
| 115 | MP0005389_reproductive_system_phenotype | 0.79254073 |
| 116 | MP0002693_abnormal_pancreas_physiology | 0.77994401 |
| 117 | * MP0002080_prenatal_lethality | 0.77094705 |
| 118 | * MP0000477_abnormal_intestine_morphology | 0.73864331 |
| 119 | MP0009840_abnormal_foam_cell | 0.73681889 |
| 120 | MP0000377_abnormal_hair_follicle | 0.72785452 |
| 121 | MP0010678_abnormal_skin_adnexa | 0.71982877 |
| 122 | MP0002060_abnormal_skin_morphology | 0.71693231 |
| 123 | MP0005058_abnormal_lysosome_morphology | 0.71376130 |
| 124 | MP0002084_abnormal_developmental_patter | 0.70793395 |
| 125 | MP0000313_abnormal_cell_death | 0.70720168 |
| 126 | MP0009053_abnormal_anal_canal | 0.69998758 |
| 127 | MP0001851_eye_inflammation | 0.69957422 |
| 128 | MP0001879_abnormal_lymphatic_vessel | 0.68937286 |
| 129 | MP0005360_urolithiasis | 0.68798134 |
| 130 | MP0005666_abnormal_adipose_tissue | 0.68694664 |
| 131 | MP0002998_abnormal_bone_remodeling | 0.68534289 |
| 132 | MP0009931_abnormal_skin_appearance | 0.68416086 |
| 133 | MP0000598_abnormal_liver_morphology | 0.68411050 |
| 134 | MP0005174_abnormal_tail_pigmentation | 0.68233624 |
| 135 | MP0001929_abnormal_gametogenesis | 0.68158048 |
| 136 | * MP0002925_abnormal_cardiovascular_devel | 0.66607210 |
| 137 | MP0002160_abnormal_reproductive_system | 0.65495785 |
| 138 | MP0004883_abnormal_blood_vessel | 0.64051879 |
| 139 | MP0002970_abnormal_white_adipose | 0.61795421 |
| 140 | MP0005647_abnormal_sex_gland | 0.61232910 |
| 141 | MP0009763_increased_sensitivity_to | 0.60465219 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.59916032 |
| 143 | MP0005319_abnormal_enzyme/_coenzyme | 0.57448294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.41838093 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.09707057 |
| 3 | Abnormality of B cell number (HP:0010975) | 4.45045445 |
| 4 | B lymphocytopenia (HP:0010976) | 4.45045445 |
| 5 | Recurrent viral infections (HP:0004429) | 4.12228977 |
| 6 | Abnormality of the fingertips (HP:0001211) | 3.92859302 |
| 7 | Panhypogammaglobulinemia (HP:0003139) | 3.92369908 |
| 8 | Autoimmune hemolytic anemia (HP:0001890) | 3.85715093 |
| 9 | Thyroiditis (HP:0100646) | 3.76641922 |
| 10 | Severe combined immunodeficiency (HP:0004430) | 3.76057707 |
| 11 | Combined immunodeficiency (HP:0005387) | 3.65139940 |
| 12 | Abnormality of T cells (HP:0002843) | 3.55744450 |
| 13 | Stomatitis (HP:0010280) | 3.29439274 |
| 14 | IgM deficiency (HP:0002850) | 3.29259442 |
| 15 | Hypoplasia of the thymus (HP:0000778) | 3.25359753 |
| 16 | Eosinophilia (HP:0001880) | 3.21753611 |
| 17 | Recurrent fungal infections (HP:0002841) | 3.21215784 |
| 18 | Recurrent bronchitis (HP:0002837) | 3.18273065 |
| 19 | Abnormality of the columella (HP:0009929) | 3.12695129 |
| 20 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.07777718 |
| 21 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.95155922 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 2.95130691 |
| 23 | Verrucae (HP:0200043) | 2.85387029 |
| 24 | Papilloma (HP:0012740) | 2.85387029 |
| 25 | Granulocytopenia (HP:0001913) | 2.72364687 |
| 26 | Abnormality of eosinophils (HP:0001879) | 2.63782399 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 2.63507816 |
| 28 | IgG deficiency (HP:0004315) | 2.56298045 |
| 29 | Recurrent abscess formation (HP:0002722) | 2.52019304 |
| 30 | Pustule (HP:0200039) | 2.51205563 |
| 31 | Agammaglobulinemia (HP:0004432) | 2.47660401 |
| 32 | Prolonged bleeding time (HP:0003010) | 2.47509970 |
| 33 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.46768489 |
| 34 | Volvulus (HP:0002580) | 2.43901541 |
| 35 | Gastrointestinal inflammation (HP:0004386) | 2.43334185 |
| 36 | Basal cell carcinoma (HP:0002671) | 2.43278905 |
| 37 | Inflammation of the large intestine (HP:0002037) | 2.42707024 |
| 38 | Cellulitis (HP:0100658) | 2.42409593 |
| 39 | Gastrointestinal infarctions (HP:0005244) | 2.42251674 |
| 40 | Long eyelashes (HP:0000527) | 2.41223371 |
| 41 | Recurrent skin infections (HP:0001581) | 2.41123360 |
| 42 | Optic neuritis (HP:0100653) | 2.40537988 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 2.40537988 |
| 44 | Lymphopenia (HP:0001888) | 2.35414042 |
| 45 | Acute lymphatic leukemia (HP:0006721) | 2.33211957 |
| 46 | Increased density of long bones (HP:0006392) | 2.32829728 |
| 47 | Chronic otitis media (HP:0000389) | 2.32749767 |
| 48 | Meningitis (HP:0001287) | 2.32402072 |
| 49 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.30979489 |
| 50 | Short 4th metacarpal (HP:0010044) | 2.30979489 |
| 51 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.30219823 |
| 52 | Encephalitis (HP:0002383) | 2.28438789 |
| 53 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.26106521 |
| 54 | Aortic aneurysm (HP:0004942) | 2.25093357 |
| 55 | Leukocytosis (HP:0001974) | 2.24891580 |
| 56 | Nasal polyposis (HP:0100582) | 2.23132126 |
| 57 | Chromsome breakage (HP:0040012) | 2.22078567 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 2.21367937 |
| 59 | Spontaneous hematomas (HP:0007420) | 2.20906223 |
| 60 | Abnormal platelet volume (HP:0011876) | 2.18783659 |
| 61 | IgA deficiency (HP:0002720) | 2.17629748 |
| 62 | Orchitis (HP:0100796) | 2.17007088 |
| 63 | Colitis (HP:0002583) | 2.16875223 |
| 64 | Abnormality of T cell physiology (HP:0011840) | 2.12593628 |
| 65 | Gingival bleeding (HP:0000225) | 2.11467421 |
| 66 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08932969 |
| 67 | Obstructive lung disease (HP:0006536) | 2.08932969 |
| 68 | Lymphoma (HP:0002665) | 2.08686308 |
| 69 | Albinism (HP:0001022) | 2.08324669 |
| 70 | Bicuspid aortic valve (HP:0001647) | 2.07450970 |
| 71 | Clumsiness (HP:0002312) | 2.06061211 |
| 72 | Abnormality of DNA repair (HP:0003254) | 2.05019245 |
| 73 | Osteolytic defects of the hand bones (HP:0009699) | 2.04657476 |
| 74 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04657476 |
| 75 | Thrombocytosis (HP:0001894) | 2.04122681 |
| 76 | Deviation of the thumb (HP:0009603) | 2.03202538 |
| 77 | Hematochezia (HP:0002573) | 2.01818031 |
| 78 | Abnormality of macrophages (HP:0004311) | 2.00919273 |
| 79 | Epistaxis (HP:0000421) | 2.00442867 |
| 80 | Thoracic kyphosis (HP:0002942) | 1.98262681 |
| 81 | Proximal placement of thumb (HP:0009623) | 1.97227641 |
| 82 | Pulmonary infiltrates (HP:0002113) | 1.96129896 |
| 83 | Ulnar bowing (HP:0003031) | 1.95481014 |
| 84 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.95355691 |
| 85 | Recurrent cutaneous fungal infections (HP:0011370) | 1.95355691 |
| 86 | Prominent nose (HP:0000448) | 1.94952998 |
| 87 | Subacute progressive viral hepatitis (HP:0006572) | 1.94098884 |
| 88 | Chest pain (HP:0100749) | 1.93300665 |
| 89 | Increased mean platelet volume (HP:0011877) | 1.92961185 |
| 90 | Macroorchidism (HP:0000053) | 1.90717734 |
| 91 | Abnormality of the nasal mucosa (HP:0000433) | 1.90236874 |
| 92 | Slow saccadic eye movements (HP:0000514) | 1.89906344 |
| 93 | Cerebral aneurysm (HP:0004944) | 1.89377458 |
| 94 | Acute myeloid leukemia (HP:0004808) | 1.88210832 |
| 95 | Hypochromic anemia (HP:0001931) | 1.88176642 |
| 96 | Keratoconjunctivitis (HP:0001096) | 1.87045275 |
| 97 | Severe visual impairment (HP:0001141) | 1.86653253 |
| 98 | Hypoproteinemia (HP:0003075) | 1.86445779 |
| 99 | Myositis (HP:0100614) | 1.85126285 |
| 100 | Deep philtrum (HP:0002002) | 1.83672912 |
| 101 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.83395262 |
| 102 | Gastrointestinal stroma tumor (HP:0100723) | 1.83209524 |
| 103 | Cutis marmorata (HP:0000965) | 1.83111563 |
| 104 | Chronic diarrhea (HP:0002028) | 1.83027035 |
| 105 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.82096578 |
| 106 | Hyperacusis (HP:0010780) | 1.81526321 |
| 107 | Pulmonary embolism (HP:0002204) | 1.81346026 |
| 108 | Syringomyelia (HP:0003396) | 1.80856354 |
| 109 | Spinal cord lesions (HP:0100561) | 1.80856354 |
| 110 | Bronchitis (HP:0012387) | 1.80614463 |
| 111 | Keratoconjunctivitis sicca (HP:0001097) | 1.80282037 |
| 112 | Periodontitis (HP:0000704) | 1.78946119 |
| 113 | Persistence of primary teeth (HP:0006335) | 1.78779157 |
| 114 | Acute hepatic failure (HP:0006554) | 1.78627431 |
| 115 | Recurrent sinusitis (HP:0011108) | 1.78134090 |
| 116 | Increased nuchal translucency (HP:0010880) | 1.77875279 |
| 117 | Arterial thrombosis (HP:0004420) | 1.77847721 |
| 118 | Mitral valve prolapse (HP:0001634) | 1.77111655 |
| 119 | Abnormality of the 4th metacarpal (HP:0010012) | 1.76813808 |
| 120 | Self-mutilation (HP:0000742) | 1.75345756 |
| 121 | Increased IgE level (HP:0003212) | 1.75212165 |
| 122 | Eczematoid dermatitis (HP:0000976) | 1.74674802 |
| 123 | Vasculitis (HP:0002633) | 1.74557674 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.74222766 |
| 125 | Narrow palate (HP:0000189) | 1.73799840 |
| 126 | Joint swelling (HP:0001386) | 1.73596627 |
| 127 | Emphysema (HP:0002097) | 1.73478222 |
| 128 | Clubbing of toes (HP:0100760) | 1.73075933 |
| 129 | Abnormality of the prostate (HP:0008775) | 1.72779130 |
| 130 | Hemoptysis (HP:0002105) | 1.72434851 |
| 131 | Bronchiectasis (HP:0002110) | 1.70812347 |
| 132 | Acanthocytosis (HP:0001927) | 1.70731134 |
| 133 | Ectopic kidney (HP:0000086) | 1.70034387 |
| 134 | Limited elbow extension (HP:0001377) | 1.68971012 |
| 135 | Spondylolisthesis (HP:0003302) | 1.68916686 |
| 136 | Abnormality of the thymus (HP:0000777) | 1.67996444 |
| 137 | Ureteral stenosis (HP:0000071) | 1.67944608 |
| 138 | Trigonocephaly (HP:0000243) | 1.67656967 |
| 139 | Rectal prolapse (HP:0002035) | 1.67502896 |
| 140 | Abnormality of the renal collecting system (HP:0004742) | 1.67005551 |
| 141 | Dislocated radial head (HP:0003083) | 1.66045854 |
| 142 | Duplicated collecting system (HP:0000081) | 1.65961647 |
| 143 | Dilatation of the ascending aorta (HP:0005111) | 1.65813414 |
| 144 | Abnormal foot bone ossification (HP:0010675) | 1.65151523 |
| 145 | Myocardial infarction (HP:0001658) | 1.63817604 |
| 146 | Disproportionate tall stature (HP:0001519) | 1.63219581 |
| 147 | Viral hepatitis (HP:0006562) | 1.62689372 |
| 148 | Genetic anticipation (HP:0003743) | 1.62577676 |
| 149 | High pitched voice (HP:0001620) | 1.61991526 |
| 150 | Abnormality of oral frenula (HP:0000190) | 1.60910474 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.01210415 |
| 2 | MAP3K13 | 3.49345507 |
| 3 | CDK12 | 3.39799136 |
| 4 | MAP3K10 | 3.19472076 |
| 5 | EEF2K | 3.04752761 |
| 6 | STK10 | 2.72527888 |
| 7 | PINK1 | 2.62482405 |
| 8 | TXK | 2.58162345 |
| 9 | PKN2 | 2.49292283 |
| 10 | TRIB3 | 2.37438191 |
| 11 | RIPK4 | 2.24148480 |
| 12 | JAK3 | 2.15671448 |
| 13 | FES | 2.05590990 |
| 14 | GRK6 | 1.93345752 |
| 15 | ITK | 1.92171524 |
| 16 | FGFR4 | 1.82707072 |
| 17 | CDC7 | 1.80095689 |
| 18 | ZAP70 | 1.75011974 |
| 19 | LRRK2 | 1.74755652 |
| 20 | FGFR3 | 1.67336919 |
| 21 | NEK2 | 1.64998875 |
| 22 | TYK2 | 1.60801428 |
| 23 | ERN1 | 1.51685412 |
| 24 | MAP3K1 | 1.49626507 |
| 25 | CDK4 | 1.47119900 |
| 26 | BTK | 1.44755146 |
| 27 | SIK1 | 1.44373743 |
| 28 | CDK6 | 1.44304604 |
| 29 | BRD4 | 1.43012646 |
| 30 | CAMK1D | 1.33340179 |
| 31 | PTK6 | 1.32507653 |
| 32 | RPS6KA4 | 1.32376145 |
| 33 | SGK2 | 1.30764759 |
| 34 | JAK1 | 1.28989403 |
| 35 | TTN | 1.26199903 |
| 36 | TLK1 | 1.24542758 |
| 37 | PIM1 | 1.20125436 |
| 38 | KSR2 | 1.18890408 |
| 39 | CSK | 1.13089404 |
| 40 | RPS6KB2 | 1.11892016 |
| 41 | ZAK | 1.09404171 |
| 42 | SYK | 1.08317556 |
| 43 | WNK1 | 1.05192483 |
| 44 | OBSCN | 1.04780515 |
| 45 | LCK | 1.04506737 |
| 46 | LATS1 | 1.04471702 |
| 47 | STK4 | 1.03507954 |
| 48 | HCK | 1.03383188 |
| 49 | NLK | 1.02940884 |
| 50 | STK3 | 1.02039471 |
| 51 | MARK3 | 1.02023417 |
| 52 | MAP3K2 | 1.02001528 |
| 53 | CSF1R | 1.01924125 |
| 54 | SGK3 | 1.01578990 |
| 55 | EPHB1 | 1.01320660 |
| 56 | FLT3 | 0.99224560 |
| 57 | TGFBR2 | 0.99069282 |
| 58 | PDGFRB | 0.98711051 |
| 59 | FGFR2 | 0.98701851 |
| 60 | MAPKAPK3 | 0.98128200 |
| 61 | CAMK1G | 0.97330304 |
| 62 | CDK9 | 0.96666828 |
| 63 | MAP3K8 | 0.96157734 |
| 64 | PIK3CG | 0.95496768 |
| 65 | SGK223 | 0.95154499 |
| 66 | SGK494 | 0.95154499 |
| 67 | MELK | 0.94847456 |
| 68 | MAP3K7 | 0.92868468 |
| 69 | TEC | 0.90511027 |
| 70 | MTOR | 0.90499222 |
| 71 | TNK2 | 0.89453743 |
| 72 | PDK1 | 0.87950560 |
| 73 | MAP3K3 | 0.86753329 |
| 74 | PRPF4B | 0.84240031 |
| 75 | ALK | 0.81483575 |
| 76 | PASK | 0.80838396 |
| 77 | MAPK12 | 0.79509419 |
| 78 | MAP3K9 | 0.79114970 |
| 79 | NUAK1 | 0.77719718 |
| 80 | EPHA3 | 0.77570143 |
| 81 | MST4 | 0.76931818 |
| 82 | MAP2K3 | 0.75015835 |
| 83 | ACVR1B | 0.74795023 |
| 84 | CHUK | 0.74118547 |
| 85 | RPS6KB1 | 0.73547147 |
| 86 | JAK2 | 0.70955239 |
| 87 | IKBKE | 0.70744494 |
| 88 | ATR | 0.69925742 |
| 89 | TESK2 | 0.67121460 |
| 90 | PDGFRA | 0.66739781 |
| 91 | MAP3K14 | 0.66359563 |
| 92 | CHEK1 | 0.66300433 |
| 93 | PRKCQ | 0.65556132 |
| 94 | TBK1 | 0.65098955 |
| 95 | SIK2 | 0.65028138 |
| 96 | TRPM7 | 0.64842691 |
| 97 | TGFBR1 | 0.64689355 |
| 98 | CDK3 | 0.64260262 |
| 99 | RET | 0.63758489 |
| 100 | CLK1 | 0.63265017 |
| 101 | NEK9 | 0.63214639 |
| 102 | DMPK | 0.62135542 |
| 103 | RIPK1 | 0.62100734 |
| 104 | SCYL2 | 0.60912972 |
| 105 | PDPK1 | 0.60349205 |
| 106 | FGFR1 | 0.60006640 |
| 107 | MAPK11 | 0.59377087 |
| 108 | CAMKK2 | 0.59293879 |
| 109 | KDR | 0.59173953 |
| 110 | FRK | 0.58336401 |
| 111 | CDK7 | 0.56635845 |
| 112 | TAOK3 | 0.55994171 |
| 113 | AURKB | 0.53745685 |
| 114 | HIPK2 | 0.53239084 |
| 115 | IRAK4 | 0.52224213 |
| 116 | GRK1 | 0.51796838 |
| 117 | KIT | 0.51541266 |
| 118 | RAF1 | 0.50263401 |
| 119 | ATM | 0.50127865 |
| 120 | PRKCH | 0.49532058 |
| 121 | EIF2AK3 | 0.49156573 |
| 122 | TAOK1 | 0.48537834 |
| 123 | BLK | 0.47972367 |
| 124 | NME2 | 0.47113153 |
| 125 | IKBKB | 0.46973031 |
| 126 | ICK | 0.46480173 |
| 127 | PAK2 | 0.45509806 |
| 128 | BMPR1B | 0.44861561 |
| 129 | LYN | 0.44815209 |
| 130 | PTK2B | 0.43704225 |
| 131 | BMX | 0.42078341 |
| 132 | PRKAA2 | 0.41518755 |
| 133 | MARK2 | 0.41395437 |
| 134 | TTK | 0.41226007 |
| 135 | MOS | 0.41169273 |
| 136 | DYRK1B | 0.40649026 |
| 137 | * CDK2 | 0.40414977 |
| 138 | PAK4 | 0.39759252 |
| 139 | MAPK7 | 0.38513033 |
| 140 | EGFR | 0.37913481 |
| 141 | SGK1 | 0.36939720 |
| 142 | BRSK2 | 0.36085785 |
| 143 | ADRBK2 | 0.36035230 |
| 144 | MATK | 0.35512106 |
| 145 | TYRO3 | 0.35274374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.35698425 |
| 2 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.30720838 |
| 3 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.28728508 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.18947446 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97293701 |
| 6 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.95796571 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.92808766 |
| 8 | Measles_Homo sapiens_hsa05162 | 1.81639005 |
| 9 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.80208492 |
| 10 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.79731338 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.73982862 |
| 12 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.63783011 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61066446 |
| 14 | Lysine degradation_Homo sapiens_hsa00310 | 1.60184062 |
| 15 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53649732 |
| 16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53033004 |
| 17 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.51974083 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.51578479 |
| 19 | DNA replication_Homo sapiens_hsa03030 | 1.50426202 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49105148 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.46303875 |
| 22 | Viral myocarditis_Homo sapiens_hsa05416 | 1.45767542 |
| 23 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.40293266 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.39309007 |
| 25 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.34445815 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30120502 |
| 27 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.26389064 |
| 28 | * HTLV-I infection_Homo sapiens_hsa05166 | 1.26237083 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24992282 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24844863 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24541705 |
| 32 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.20446386 |
| 33 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.18813133 |
| 34 | Mismatch repair_Homo sapiens_hsa03430 | 1.18437203 |
| 35 | * Hepatitis B_Homo sapiens_hsa05161 | 1.17883543 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16833740 |
| 37 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.16616740 |
| 38 | Spliceosome_Homo sapiens_hsa03040 | 1.16234082 |
| 39 | Adherens junction_Homo sapiens_hsa04520 | 1.15558672 |
| 40 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.15384944 |
| 41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.13665081 |
| 42 | Olfactory transduction_Homo sapiens_hsa04740 | 1.10108256 |
| 43 | RNA transport_Homo sapiens_hsa03013 | 1.07281966 |
| 44 | Colorectal cancer_Homo sapiens_hsa05210 | 1.07035345 |
| 45 | Thyroid cancer_Homo sapiens_hsa05216 | 1.04613484 |
| 46 | Prostate cancer_Homo sapiens_hsa05215 | 1.02334328 |
| 47 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.01671398 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00964236 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 1.00147404 |
| 50 | Base excision repair_Homo sapiens_hsa03410 | 0.99743430 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.96051452 |
| 52 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95836698 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.94904605 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.93860183 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.92484155 |
| 56 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90582387 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89362272 |
| 58 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86820948 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 0.86150715 |
| 60 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.85772196 |
| 61 | Influenza A_Homo sapiens_hsa05164 | 0.85295822 |
| 62 | Endometrial cancer_Homo sapiens_hsa05213 | 0.84974818 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 0.84776456 |
| 64 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.84241059 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.83416244 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.82349847 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79231158 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78811067 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76682247 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.75886327 |
| 71 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75853289 |
| 72 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75663472 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.74800609 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73617316 |
| 75 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.71305631 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70220890 |
| 77 | Focal adhesion_Homo sapiens_hsa04510 | 0.69308081 |
| 78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69098727 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68167630 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67649141 |
| 81 | Renin secretion_Homo sapiens_hsa04924 | 0.67261758 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.67198917 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65987610 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | 0.65590091 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.65290627 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.63849192 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.63775560 |
| 88 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63772728 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63548243 |
| 90 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61794231 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61309989 |
| 92 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61202745 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60899232 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60650624 |
| 95 | Circadian rhythm_Homo sapiens_hsa04710 | 0.60559076 |
| 96 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59880500 |
| 97 | Ribosome_Homo sapiens_hsa03010 | 0.59397070 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.58942550 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.58081232 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.56686699 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55813178 |
| 102 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53461648 |
| 103 | Malaria_Homo sapiens_hsa05144 | 0.52914344 |
| 104 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52541706 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51042617 |
| 106 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.49974931 |
| 107 | Phototransduction_Homo sapiens_hsa04744 | 0.49648882 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49624036 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.49522642 |
| 110 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49389047 |
| 111 | Tuberculosis_Homo sapiens_hsa05152 | 0.48682210 |
| 112 | Homologous recombination_Homo sapiens_hsa03440 | 0.47951958 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47535860 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47203407 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46582517 |
| 116 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.45595640 |
| 117 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45379547 |
| 118 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.45375923 |
| 119 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45109625 |
| 120 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44091734 |
| 121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43909808 |
| 122 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.43698060 |
| 123 | Alcoholism_Homo sapiens_hsa05034 | 0.43540182 |
| 124 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43167614 |
| 125 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.43133870 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42803835 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41811466 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41800877 |
| 129 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.41678897 |
| 130 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40458317 |
| 131 | Long-term potentiation_Homo sapiens_hsa04720 | 0.39813931 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.34855790 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30015463 |

